Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Medical College of Wisconsin
Wake Forest University Health Sciences
National Institutes of Health Clinical Center (CC)
Emory University
Eli Lilly and Company
H. Lee Moffitt Cancer Center and Research Institute
Guerbet
M.D. Anderson Cancer Center
University of Alabama at Birmingham
Thomas Jefferson University
Children's Hospital Los Angeles
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)
Blue Earth Diagnostics
Massachusetts General Hospital
National Institutes of Health Clinical Center (CC)
Yale University
National Institutes of Health Clinical Center (CC)
Blue Earth Diagnostics
Istari Oncology, Inc.
Hackensack Meridian Health
Columbia University
University of Pittsburgh
MedSIR
Bristol-Myers Squibb
Istari Oncology, Inc.
Massachusetts General Hospital
St. Joseph's Hospital and Medical Center, Phoenix
Grupo Español Multidisciplinar de Melanoma
Thomas Jefferson University
Thomas Jefferson University
Thomas Jefferson University
Monteris Medical
NRG Oncology
Cordgenics, LLC
Virginia Commonwealth University
Memorial Sloan Kettering Cancer Center
Case Comprehensive Cancer Center
BeiGene
Children's Oncology Group
Wake Forest University Health Sciences
Wake Forest University Health Sciences
University of Cincinnati
Milton S. Hershey Medical Center
National Institutes of Health Clinical Center (CC)
Virginia Commonwealth University
Boston Children's Hospital
Blaze Bioscience Inc.
ImmunityBio, Inc.